NOTCH2 Antibody PE 12-5786-82 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

Flow

Staining of unstimulated (blue histogram) or 24-hour anti-CD3-stimulated (Product # 16-0031-82) (purple histogram) C57Bl/6 splenocytes with 0.5 µg of Anti-Mouse Notch2 PE. Cells in the lymphocyte gate were used for analysis.
Flow

Staining of unstimulated (blue histogram) or 24-hour anti-CD3-stimulated (Product # 16-0031-82) (purple histogram) C57Bl/6 splenocytes with 0.5 µg of Anti-Mouse Notch2 PE. Cells in the lymphocyte gate were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
NOTCH2 Antibody PE

The NOTCH2 Antibody PE from Thermo Fisher Scientific is a Rat Monoclonal antibody to Notch 2, notch receptor 2, and NOTCH2. This antibody recognizes Homo Sapiens, Human, and Mouse antigen. The NOTCH2 Antibody PE has been validated for the following applications: Flow Cytometry.

Product Specs
ItemNOTCH2 Antibody PE
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number12-5786-82
Quantity100 µg
ApplicationsFlow Cytometry
Concentration0.2 mg/mL
Conjugate/TagPE
FormatPBS with 0.09% sodium azide; pH 7.2
ReactivityHuman, Mouse
TargetNOTCH2
IsotypeIgG1 kappa
Clone16F11
HostRat
NCBI Full Gene Namenotch 2, notch receptor 2
NCBI Gene AliasesN2, AGS2, HJCYS, hN2
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathwaysMolecular cancerMarch 7, 2017Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M.

(2) NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AMLBloodMay 1, 2014Adamia S, Bar-Natan M, Haibe-Kains B, Pilarski PM, Bach C, Pevzner S, Calimeri T, Avet-Loiseau H, Lode L, Verselis S, et al.

(3) Notch pathway activation targets AML-initiating cell homeostasis and differentiationThe Journal of experimental medicineFebruary 11, 2013Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, et al.

(4) Interleukin-19: a constituent of the regulome that controls antigen presenting cells in the lungs and airway responses to microbial productsPloS oneJanuary 1, 2011Hoffman C, Park SH, Daley E, Emson C, Louten J, Sisco M, de Waal Malefyt R, Grunig G.

Be the First to Write a Review!